Cardiac Pharmacotherapy


Cardiac pharmacotherapy plays a major role in the management of cardiovascular disease. Drug treatment leads to lifelong interventions in various cardiovascular conditions and increases life expectancy levels, leading to its role in increasing other debilitating symptoms. Various heart agents are available to treat a variety of heart conditions. There are about 6 organizations and 50 communities and universities that work on heart drugs. Of these, the main association of cardiology medical staff is the U.S. Cardiovascular drugs are available on the market that include cardiac glycosides, anticoagulants, antiarrhythmic agents, antigenic agents and antihypertensive agents.



 


  • Renin-Angiotensin-Aldosterone system
  • Neural Control of the cardiovascular system
  • Pharmacokinetics
  • Platelet/Clotting system

Related Conference of Cardiac Pharmacotherapy

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Cardiac Pharmacotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in